Byondis, BYON14156, Antibody-Drug Conjugates, ADC, World ADC, Antifolate, ADC Payload, Payload Resistance, ByonGuard, Steric Masking, Drug-Linker Technology, Cancer Therapy

NIJMEGEN, Netherlands — October 7, 2026 Byondis announced that it will present progress across its proprietary antibody-drug conjugate (ADC)...